• Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg110Valfs*13 (c.328delC); ClinVar=VCV000127807; Zygosity=Unspecified (PubMed=12794755).
  

PubMed=2540905
Takahashi T., Obata Y., Sekido Y., Hida T., Ueda R., Watanabe H., Ariyoshi Y., Sugiura T., Takahashi T.
Expression and amplification of myc gene family in small cell lung cancer and its relation to biological characteristics.
Cancer Res. 49:2683-2688(1989)

PubMed=1710138; PMCID=PMC2204105
Hida T., Koike K., Sekido Y., Nishida K., Sugiura T., Ariyoshi Y., Takahashi T., Ueda R.
Epitope analysis of cluster 1 and NK cell-related monoclonal antibodies.
Br. J. Cancer Suppl. 14:24-28(1991)

PubMed=8384671; DOI=10.1093/oxfordjournals.jjco.a039602
Hida T., Ariyoshi Y., Kuwabara M., Sugiura T., Takahashi T., Takahashi T., Hosoda K., Niitsu Y., Ueda R.
Glutathione S-transferase pi levels in a panel of lung cancer cell lines and its relation to chemo-radiosensitivity.
Jpn. J. Clin. Oncol. 23:14-19(1993)

PubMed=7834619
Washimi O., Nagatake M., Osada H., Ueda R., Koshikawa T., Seki T., Takahashi T., Takahashi T.
In vivo occurrence of p16 (MTS1) and p15 (MTS2) alterations preferentially in non-small cell lung cancers.
Cancer Res. 55:514-517(1995)

PubMed=12794755; DOI=10.1002/ijc.11184
Endoh H., Yatabe Y., Shimizu S., Tajima K., Kuwano H., Takahashi T., Mitsudomi T.
RASSF1A gene inactivation in non-small cell lung cancer and its clinical implication.
Int. J. Cancer 106:45-51(2003)